Envarsus XR 0.75 MG tablet 100S
Ended Awarded Last action
- Contract number
- SPE2DR26FU791
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,038
Award facts
- Contract value 100% obligated
- $2,037.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $2,037.96 delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Envarsus XR 0.75 mg tablets (100-count units). This firm fixed-price delivery order, with an ultimate completion date of January 8, 2026, represents a competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. As the prime contractor under the SPE2DX IDC, the company supplies an extensive portfolio of pharmaceutical products and medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Envarsus XR is a tacrolimus-based immunosuppressant medication used primarily in transplant care, reflecting AmerisourceBergen's critical role in supplying specialized medical commodities to federal healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FU791?
SPE2DR26FU791 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DR26FU791 worth?
The government has obligated $2,038 on SPE2DR26FU791.
Is contract SPE2DR26FU791 an order under another contract?
Yes. SPE2DR26FU791 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FU791 competed?
The extent of competition for SPE2DR26FU791 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award